NeoRx signs supply deal with Cordis

Article

Monoclonal antibody developerNeoRx of Seattle has signed an agreement with catheter maker Cordisof Miami in which Cordis will supply its Micro-Infusion Catheter(MIC) for use with NeoRx's Biostent anti-restenosis product underdevelopment. The MIC will be

Monoclonal antibody developerNeoRx of Seattle has signed an agreement with catheter maker Cordisof Miami in which Cordis will supply its Micro-Infusion Catheter(MIC) for use with NeoRx's Biostent anti-restenosis product underdevelopment. The MIC will be used to deliver Biostent immediatelyafter balloon angioplasty.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.